Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Diag Capital Management, LP (CIK 1687807) reported $87.4M across 40 reported positions in its SEC 13F filing for 2018-12-31. Largest positions: BAX ($5.7M, 6.47%), ATNXQ ($5.4M, 6.23%), ZBH ($4.9M, 5.66%), ABBV ($4.6M, 5.32%), INCY ($4.6M, 5.25%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | BAX | BAXTER INTL INC | $5.7M | 6.47% | 85,933 | New |
| 2 | ATNXQ | ATHENEX INC | $5.4M | 6.23% | 429,046 | New |
| 3 | ZBH | ZIMMER BIOMET HLDGS INC | $4.9M | 5.66% | 47,684 | New |
| 4 | ABBV | ABBVIE INC | $4.6M | 5.32% | 50,420 | New |
| 5 | INCY | INCYTE CORP | $4.6M | 5.25% | 72,196 | New |
| 6 | QTRX | QUANTERIX CORP | $4.1M | 4.69% | 223,949 | New |
| 7 | CELG | CELGENE CORP | $4.0M | 4.63% | 63,159 | New |
| 8 | AMGN | AMGEN INC | $3.9M | 4.48% | 20,110 | New |
| 9 | MDT | MEDTRONIC PLC | $3.3M | 3.76% | 36,180 | New |
| 10 | QTNT | QUOTIENT LTD | $3.2M | 3.69% | 526,932 | New |
| 11 | PCRX | PACIRA PHARMACEUTICALS INC | $3.2M | 3.67% | 74,502 | New |
| 12 | TAK | TAKEDA PHARMACEUTICAL CO LTD | $3.0M | 3.41% | 177,260 | New |
| 13 | ZLAB | ZAI LAB LTD | $2.8M | 3.19% | 120,092 | New |
| 14 | ABT | ABBOTT LABS | $2.8M | 3.19% | 38,585 | New |
| 15 | VTRS | MYLAN N V | $2.7M | 3.12% | 99,410 | New |
| 16 | PTEIQ | POLARITYTE INC | $2.5M | 2.82% | 182,833 | New |
| 17 | VRAY | VIEWRAY INC | $2.4M | 2.76% | 397,375 | New |
| 18 | REGN | REGENERON PHARMACEUTICALS | $2.2M | 2.47% | 5,792 | New |
| 19 | AKRXQ | AKORN INC | $2.1M | 2.46% | 634,046 | New |
| 20 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $2.2M | 2.46% | 139,531 | New |
| 21 | HAE | HAEMONETICS CORP | $2.1M | 2.43% | 21,220 | New |
| 22 | ARGX | ARGENX SE | $1.6M | 1.84% | 16,712 | New |
| 23 | BHVN1 | BIOHAVEN PHARMACTL HLDG CO L | $1.4M | 1.62% | 38,319 | New |
| 24 | MMSI | MERIT MED SYS INC | $1.4M | 1.60% | 25,092 | New |
| 25 | GWPH | GW PHARMACEUTICALS PLC | $1.3M | 1.50% | 13,460 | New |
Source: SEC Form 13F filings · as of 2018-12-31